Ningbo David Medical Device Co., Ltd. Stock

Equities

300314

CNE100001DD1

Medical Equipment, Supplies & Distribution

End-of-day quote Shenzhen S.E. 06:00:00 2024-04-24 pm EDT 5-day change 1st Jan Change
10.57 CNY +0.67% Intraday chart for Ningbo David Medical Device Co., Ltd. +1.44% -30.18%
Sales 2024 * 971M 134M Sales 2025 * 1.29B 179M Capitalization 3.04B 421M
Net income 2024 * 276M 38.13M Net income 2025 * 363M 50.15M EV / Sales 2024 * 3.13 x
Net cash position 2024 * - 0 Net cash position 2025 * - 0 EV / Sales 2025 * 2.35 x
P/E ratio 2024 *
11 x
P/E ratio 2025 *
8.39 x
Employees 867
Yield 2024 *
-
Yield 2025 *
-
Free-Float 23.67%
More Fundamentals * Assessed data
Dynamic Chart
Ningbo David Medical Device Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Ningbo David Medical Device Co., Ltd. Proposes Final Cash Dividend for the Year 2023 CI
Ningbo David Medical Device Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
Ningbo David Medical Device Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023 CI
Ningbo David Medical Device Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023 CI
Ningbo David Medical Device Co., Ltd. Approves Final Cash Dividend on A Shares for the Year 2022, Payable on 09 May 2023 CI
Ningbo David Medical Device Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Ningbo David Medical Device Co., Ltd. Proposes Final Cash Dividend for the Year 2022 CI
Ningbo David Medical Device Co., Ltd. Announces Executive Elections CI
Ningbo David Medical Device Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022 CI
Ningbo David Medical Device Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2022 CI
Ningbo David Medical Device Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022 CI
Ningbo David Medical Device Co., Ltd. Approves Cash Dividend for 2021 CI
Ningbo David Medical Device Co., Ltd. Proposes Cash Dividend for 2021 CI
Ningbo David Medical Device Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021 CI
More news
1 day+0.67%
1 week+1.44%
Current month-5.46%
1 month-7.69%
3 months-16.97%
6 months-15.64%
Current year-30.18%
More quotes
1 week
9.81
Extreme 9.81
10.73
1 month
9.81
Extreme 9.81
12.10
Current year
8.23
Extreme 8.23
15.65
1 year
8.23
Extreme 8.23
22.63
3 years
8.23
Extreme 8.23
22.63
5 years
7.64
Extreme 7.64
27.67
10 years
7.14
Extreme 7.14
58.85
More quotes
Managers TitleAgeSince
Chief Executive Officer 55 10-08-11
Director of Finance/CFO 50 96-02-29
Director/Board Member 42 -
Members of the board TitleAgeSince
Director of Finance/CFO 50 96-02-29
Chief Executive Officer 55 10-08-11
Director/Board Member 52 92-09-17
More insiders
Date Price Change Volume
24-04-25 10.57 +0.67% 2,920,600
24-04-24 10.5 +0.67% 2,714,000
24-04-23 10.43 +2.46% 3,225,800
24-04-22 10.18 -2.86% 5,431,800
24-04-19 10.48 +0.58% 3,201,900

End-of-day quote Shenzhen S.E., April 24, 2024

More quotes
Ningbo David Medical Device Co Ltd is a China-based company mainly engaged in the research, development, production and sales of medical devices. The Company operates primarily through three segments. The Pediatric and Obstetric Care Equipment segment is mainly engaged in the research and development, production and sales of pediatric and obstetric care equipment. The Minimally Invasive Surgical Instruments segment is mainly engaged in the production and sales of special tools and equipment for minimally invasive surgeries. The Other segment is primarily engaged in the production and sales of emergency surgery and intensive care unit (ICU) medical equipment and instruments. The Company's products mainly include infant incubators, infant radiant warming tables, neonatal jaundice treatment equipment, jaundice detection equipment, electric endoscopic staplers, manual endoscopic staplers and open series staplers. The Company mainly conducts its businesses in the domestic market.
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
10.57
Average target price
-
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 300314 Stock